Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $205.50. The company's market cap stands at 499.59B, with a P/E ratio of 19.97 and a dividend yield of 2.5%.
On 2026-01-02, Johnson & Johnson(JNJ) stock traded between a low of $203.69 and a high of $208.00. Shares are currently priced at $205.50, which is +0.9% above the low and -1.2% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 6.26M, against a daily average of 7.31M.
During the past year, Johnson & Johnson(JNJ) stock moved between $140.68 at its lowest and $215.19 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $140.68 at its lowest and $215.19 at its peak.
JNJ News
These income stocks could be great buys to add to your portfolio. Market downturns are inevitable. Accepting this fact can help you avoid making fear-based dec...
Investors in Johnson & Johnson (Symbol: JNJ) saw new options begin trading today, for the February 2026 expiration. At Stock Options Channel , our YieldBoost fo...
Investors seeking reliable dividends will find that this trio of healthcare stocks offers an exciting combination of safety, growth, and income. Most dividend...
Analyst ratings
56%
of 27 ratingsMore JNJ News
Barclays raised the firm’s price target on Johnson & Johnson to $217 from $197 and keeps an Equal Weight rating on the shares. The firm’s analysis of sales and...
After Johnson & Johnson (JNJ) recently reported that the Phase 2b DUPLEX-AD proof-of-concept study of JNJ-95475939 for the treatment of moderate to severe atopi...
Key Points Microsoft is a terrific growth stock with an excellent dividend program. Johnson & Johnson and Coca-Cola are both outstanding dividend payers. How...